In Brief Valierie Armstead joins Fox Chase Cancer Center as professor in anesthesiology November 11, 2016Vol.42 No.42
Drugs & Targets LEE011, Novartis’s selective cyclin dependent kinase inhibitor, granted FDA Priority Review November 11, 2016Vol.42 No.42
Conversation with The Cancer Letter FDA Eager to Approve PD-1 and PD-L1 Drugs in Novel Combinations, New Settings November 11, 2016Vol.42 No.42By Paul Goldberg
Fred Hutchinson Opens Cellular Immunotherapy Clinic November 11, 2016Vol.42 No.42By Matthew Bin Han Ong
In Brief ASCO and Innovative Oncology Business Solutions collaborate on medical home program November 04, 2016Vol.42 No.41
In Brief O’Connell receives ACCC Research Award; Presant receives David King Award November 04, 2016Vol.42 No.41
Drugs & Targets Roche Receives FDA Approval for Tecentriq Complementary Diagnostic in NSCLC November 04, 2016Vol.42 No.41
